Korea United Pharm Inc. (KRX:033270)
19,010
-60 (-0.31%)
Feb 20, 2025, 9:00 AM KST
Korea United Pharm Revenue
Korea United Pharm had revenue of 39.95B KRW in the quarter ending September 30, 2015, with 6.10% growth. This brings the company's revenue in the last twelve months to 161.44B, up 8.00% year-over-year. In the year 2014, Korea United Pharm had annual revenue of 155.19B with 13.37% growth.
Revenue (ttm)
161.44B
Revenue Growth
+8.00%
P/S Ratio
1.89
Revenue / Employee
242.76M
Employees
665
Market Cap
282.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2014 | 155.19B | 18.30B | 13.37% |
Dec 31, 2013 | 136.89B | 2.06B | 1.53% |
Dec 31, 2012 | 134.83B | -10.62B | -7.30% |
Dec 31, 2011 | 145.45B | 10.47B | 7.76% |
Dec 31, 2010 | 134.98B | 15.89B | 13.35% |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Mar 31, 2007 | Pro | Pro | Pro |
Mar 31, 2006 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
SK Biopharmaceuticals | 511.33B |
Yuhan | 2,008.84B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanmi Science | 1,283.65B |
Hanall Biopharma | 134.24B |